Market Overview

UPDATE: JP Morgan Initiates IMAX Corporation with Overweight, $30 PT on Growth Outlook

Share:
Related IMAX
A Record-Breaking Box Office Weekend
IMAX Announces Appointment Of Dana Settle To Board Of Directors
Four Key Takeaways From IMAX's Second Quarter Earnings Report (Seeking Alpha)

JP Morgan initiates its coverage on IMAX Corporation (NYSE: IMAX) with a rating of Overweight and a price target of $30.

JP Morgan notes, "We are initiating coverage of IMAX with an Overweight rating and $30 Dec 2012 price target. We find shares attractive for a high visibility, long-term growth story that is one of the few plays on emerging market box office growth. IMAX also benefits from a unique business model within the industry that delivers high profitability and recurring FCF generation with every screen added to its network. The company has established itself as a valuable brand to both consumers and filmmakers, which we expect will help maintain its advantaged position in the global theatrical industry."

IMAX closed at $24.03 on Friday.

Latest Ratings for IMAX

DateFirmActionFromTo
Jul 2015Piper JaffrayUpgradesNeutralOverweight
Jun 2015B RileyMaintainsBuy
Jun 2015Credit SuisseMaintainsOutperform

View More Analyst Ratings for IMAX
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Price Target Initiation Intraday Update Analyst Ratings

 

Related Articles (IMAX)

Get Benzinga's Newsletters